Tumoral <i>TP53</i> and/or <i>CDKN2A</i> alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group - Concepedia

Concepedia

Publication | Closed Access

Tumoral <i>TP53</i> and/or <i>CDKN2A</i> alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group

51

Citations

42

References

2014

Year

Daniel M. Lerman, Michael J. Monument, Elizabeth McIlvaine, Xiao‐qiong Liu, Dali Huang, Laura Monovich, Natalie Beeler, Richard Görlick, Neyssa Marina, Richard B. Womer,

Pediatric Blood & Cancer

Abstract

Although previous retrospective studies suggest their significance, TP53 mutation and/or CDKN2A deletion are not reliable prognostic biomarkers in localized Ewing sarcoma.

References

	Year	Citations

Page 1